159 related articles for article (PubMed ID: 24760606)
1. Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.
Rwigemera A; Mamelona J; Martin LJ
Cell Biol Toxicol; 2014 Jun; 30(3):157-67. PubMed ID: 24760606
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
Rwigemera A; Mamelona J; Martin LJ
Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
[TBL] [Abstract][Full Text] [Related]
3. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.
Martin LJ
Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004
[TBL] [Abstract][Full Text] [Related]
4. Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells.
Konishi I; Hosokawa M; Sashima T; Kobayashi H; Miyashita K
Comp Biochem Physiol C Toxicol Pharmacol; 2006; 142(1-2):53-9. PubMed ID: 16337836
[TBL] [Abstract][Full Text] [Related]
5. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol.
Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N
Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
Asai A; Sugawara T; Ono H; Nagao A
Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells.
Zeng J; Zhang Y; Ruan J; Yang Z; Wang C; Hong Z; Zuo Z
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5582-5589. PubMed ID: 29222657
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
9. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
10. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
Tafuku S; Ishikawa C; Yasumoto T; Mori N
Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
12. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
Rabi T; Huwiler A; Zangemeister-Wittke U
Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
14. Indole-3-carbinol-induced modulation of NF-kappaB signalling is breast cancer cell-specific and does not correlate with cell death.
Moiseeva EP; Heukers R
Breast Cancer Res Treat; 2008 Jun; 109(3):451-62. PubMed ID: 17653853
[TBL] [Abstract][Full Text] [Related]
15. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.
Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE
Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100
[TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
17. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway.
Jin Y; Qiu S; Shao N; Zheng J
Med Sci Monit; 2018 Jan; 24():11-18. PubMed ID: 29291370
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma.
Rokkaku T; Kimura R; Ishikawa C; Yasumoto T; Senba M; Kanaya F; Mori N
Int J Oncol; 2013 Oct; 43(4):1176-86. PubMed ID: 23857515
[TBL] [Abstract][Full Text] [Related]
19. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
Li F; Wang Y; Wang X; Li J; Cui H; Niu M
Int J Clin Pharmacol Ther; 2012 Oct; 50(10):712-21. PubMed ID: 22762853
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
